Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Acadia Healthcare Co Inc has a consensus price target of $73.42 based on the ratings of 20 analysts. The high is $103 issued by SVB Leerink on August 26, 2022. The low is $28 issued by Barclays on May 14, 2025. The 3 most-recent analyst ratings were released by Mizuho, Barclays, and Keybanc on May 14, 2025, respectively. With an average price target of $38.33 between Mizuho, Barclays, and Keybanc, there's an implied 46.53% upside for Acadia Healthcare Co Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/14/2025 | Buy Now | 22.32% | Mizuho | Ann Hynes85% | $37 → $32 | Maintains | Neutral | Get Alert |
05/14/2025 | Buy Now | 7.03% | Barclays | Andrew Mok57% | $35 → $28 | Maintains | Equal-Weight | Get Alert |
05/14/2025 | Buy Now | 110.24% | Keybanc | Matthew Gillmor55% | $65 → $55 | Maintains | Overweight | Get Alert |
04/09/2025 | Buy Now | 37.61% | Guggenheim | Jason Cassorla18% | → $36 | Initiates | → Buy | Get Alert |
03/25/2025 | Buy Now | 41.44% | Mizuho | Ann Hynes85% | $48 → $37 | Maintains | Neutral | Get Alert |
03/03/2025 | Buy Now | 64.37% | RBC Capital | Ben Hendrix59% | $64 → $43 | Maintains | Outperform | Get Alert |
03/03/2025 | Buy Now | 148.47% | Keybanc | Matthew Gillmor55% | $70 → $65 | Maintains | Overweight | Get Alert |
02/28/2025 | Buy Now | 33.79% | Barclays | Andrew Mok57% | $43 → $35 | Downgrade | Overweight → Equal-Weight | Get Alert |
02/28/2025 | Buy Now | 70.11% | B of A Securities | Kevin Fischbeck67% | $50 → $44.5 | Maintains | Buy | Get Alert |
01/10/2025 | Buy Now | 144.65% | RBC Capital | Ben Hendrix59% | $64 → $64 | Reiterates | Outperform → Outperform | Get Alert |
01/07/2025 | Buy Now | 152.29% | TD Cowen | Ryan Langston27% | $70 → $66 | Maintains | Buy | Get Alert |
01/07/2025 | Buy Now | 167.58% | Keybanc | Matthew Gillmor55% | → $70 | Upgrade | Sector Weight → Overweight | Get Alert |
12/12/2024 | Buy Now | 186.7% | Deutsche Bank | Pito Chickering68% | $45 → $75 | Upgrade | Hold → Buy | Get Alert |
12/10/2024 | Buy Now | 98.78% | Cantor Fitzgerald | Sarah James50% | $52 → $52 | Reiterates | Neutral → Neutral | Get Alert |
11/22/2024 | Buy Now | 64.37% | Barclays | Andrew Mok57% | $76 → $43 | Maintains | Overweight | Get Alert |
11/18/2024 | Buy Now | 144.65% | RBC Capital | Ben Hendrix59% | $94 → $64 | Maintains | Outperform | Get Alert |
10/11/2024 | Buy Now | — | Keybanc | Matthew Gillmor55% | — | Initiates | → Sector Weight | Get Alert |
10/04/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
10/01/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
09/30/2024 | Buy Now | 190.52% | Barclays | Andrew Mok57% | $83 → $76 | Maintains | Overweight | Get Alert |
09/20/2024 | Buy Now | 259.33% | RBC Capital | Ben Hendrix59% | $94 → $94 | Reiterates | Outperform → Outperform | Get Alert |
08/20/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
08/19/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
08/02/2024 | Buy Now | 186.7% | Deutsche Bank | Pito Chickering68% | $70 → $75 | Maintains | Hold | Get Alert |
08/02/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
08/01/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
08/01/2024 | Buy Now | 217.28% | Barclays | Andrew Mok57% | $89 → $83 | Maintains | Overweight | Get Alert |
07/10/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
07/09/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
07/02/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
05/22/2024 | Buy Now | 259.33% | RBC Capital | Ben Hendrix59% | $94 → $94 | Reiterates | Outperform → Outperform | Get Alert |
05/17/2024 | Buy Now | 247.86% | TD Cowen | Gary Taylor59% | $101 → $91 | Maintains | Buy | Get Alert |
05/15/2024 | Buy Now | 240.21% | Barclays | Andrew Mok57% | $91 → $89 | Maintains | Overweight | Get Alert |
05/03/2024 | Buy Now | 167.58% | Mizuho | Ann Hynes85% | $84 → $70 | Maintains | Neutral | Get Alert |
05/02/2024 | Buy Now | 244.04% | B of A Securities | Kevin Fischbeck67% | $105 → $90 | Maintains | Buy | Get Alert |
05/02/2024 | Buy Now | 247.86% | Barclays | Andrew Mok57% | $100 → $91 | Maintains | Overweight | Get Alert |
04/25/2024 | Buy Now | 167.58% | Deutsche Bank | Pito Chickering68% | → $70 | Upgrade | Sell → Hold | Get Alert |
03/06/2024 | Buy Now | 221.1% | Mizuho | Ann Hynes85% | $77 → $84 | Maintains | Neutral | Get Alert |
03/06/2024 | Buy Now | 282.26% | Barclays | Andrew Mok57% | → $100 | Initiates | → Overweight | Get Alert |
03/05/2024 | Buy Now | 244.04% | Cantor Fitzgerald | Sarah James50% | $90 → $90 | Reiterates | Neutral → Neutral | Get Alert |
03/04/2024 | Buy Now | 259.33% | RBC Capital | Ben Hendrix59% | $94 → $94 | Reiterates | Outperform → Outperform | Get Alert |
03/01/2024 | Buy Now | 286.09% | TD Cowen | Gary Taylor59% | $86 → $101 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | 289.91% | UBS | Andrew Mok57% | $88 → $102 | Maintains | Buy | Get Alert |
01/05/2024 | Buy Now | 251.68% | Stephens & Co. | Scott Fidel69% | → $92 | Upgrade | Equal-Weight → Overweight | Get Alert |
11/07/2023 | Buy Now | 259.33% | RBC Capital | Ben Hendrix59% | $99 → $94 | Maintains | Outperform | Get Alert |
09/14/2023 | Buy Now | 224.92% | Cantor Fitzgerald | Joseph France64% | $83 → $85 | Maintains | Neutral | Get Alert |
07/31/2023 | Buy Now | 278.44% | RBC Capital | Ben Hendrix59% | $93 → $99 | Maintains | Outperform | Get Alert |
07/31/2023 | Buy Now | 263.15% | Credit Suisse | A.J. Rice69% | → $95 | Reiterates | Outperform → Outperform | Get Alert |
07/28/2023 | Buy Now | 236.39% | UBS | Andrew Mok57% | $92 → $88 | Maintains | Buy | Get Alert |
07/12/2023 | Buy Now | 217.28% | Stephens & Co. | Scott Fidel69% | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
06/02/2023 | Buy Now | 217.28% | Stephens & Co. | Scott Fidel69% | → $83 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
05/04/2023 | Buy Now | 263.15% | Credit Suisse | A.J. Rice69% | $93 → $95 | Maintains | Outperform | Get Alert |
04/28/2023 | Buy Now | 263.15% | Credit Suisse | Jonathan Yong65% | $93 → $95 | Maintains | Outperform | Get Alert |
04/27/2023 | Buy Now | 236.39% | Stephens & Co. | Scott Fidel69% | → $88 | Reiterates | → Equal-Weight | Get Alert |
04/24/2023 | Buy Now | 251.68% | UBS | Andrew Mok57% | $96 → $92 | Maintains | Buy | Get Alert |
04/20/2023 | Buy Now | 140.83% | Deutsche Bank | Pito Chickering68% | $75 → $63 | Downgrade | Hold → Sell | Get Alert |
03/06/2023 | Buy Now | 186.7% | Deutsche Bank | Pito Chickering68% | $82 → $75 | Maintains | Hold | Get Alert |
03/06/2023 | Buy Now | 205.81% | Mizuho | Ann Hynes85% | $87 → $80 | Maintains | Neutral | Get Alert |
03/01/2023 | Buy Now | 236.39% | Stephens & Co. | Scott Fidel69% | $92 → $88 | Maintains | Equal-Weight | Get Alert |
02/28/2023 | Buy Now | 251.68% | Stephens & Co. | Scott Fidel69% | → $92 | Reiterates | → Equal-Weight | Get Alert |
12/12/2022 | Buy Now | 255.5% | RBC Capital | Ben Hendrix59% | $94 → $93 | Maintains | Outperform | Get Alert |
12/12/2022 | Buy Now | 263.15% | Loop Capital | Joseph France64% | → $95 | Upgrade | Hold → Buy | Get Alert |
12/08/2022 | Buy Now | 232.57% | Mizuho | Ann Hynes85% | $80 → $87 | Maintains | Neutral | Get Alert |
12/08/2022 | Buy Now | 236.39% | Stephens & Co. | Scott Fidel69% | $86 → $88 | Maintains | Equal-Weight | Get Alert |
11/02/2022 | Buy Now | 228.75% | Stephens & Co. | Scott Fidel69% | $85 → $86 | Maintains | Equal-Weight | Get Alert |
11/02/2022 | Buy Now | 205.81% | Mizuho | Ann Hynes85% | $78 → $80 | Maintains | Neutral | Get Alert |
08/26/2022 | Buy Now | 293.73% | SVB Leerink | Whit Mayo67% | $95 → $103 | Maintains | Outperform | Get Alert |
08/01/2022 | Buy Now | 259.33% | RBC Capital | Frank Morgan45% | $84 → $94 | Maintains | Outperform | Get Alert |
08/01/2022 | Buy Now | 282.26% | Raymond James | John Ransom76% | $85 → $100 | Maintains | Strong Buy | Get Alert |
07/29/2022 | Buy Now | 198.17% | Mizuho | Ann Hynes85% | $69 → $78 | Maintains | Neutral | Get Alert |
07/29/2022 | Buy Now | 224.92% | Barclays | Sarah James50% | $75 → $85 | Maintains | Underweight | Get Alert |
07/28/2022 | Buy Now | 244.04% | UBS | Andrew Mok57% | $82 → $90 | Maintains | Buy | Get Alert |
06/17/2022 | Buy Now | — | Loop Capital | Joseph France64% | — | Initiates | → Hold | Get Alert |
The latest price target for Acadia Healthcare Co (NASDAQ:ACHC) was reported by Mizuho on May 14, 2025. The analyst firm set a price target for $32.00 expecting ACHC to rise to within 12 months (a possible 22.32% upside). 31 analyst firms have reported ratings in the last year.
The latest analyst rating for Acadia Healthcare Co (NASDAQ:ACHC) was provided by Mizuho, and Acadia Healthcare Co maintained their neutral rating.
The last upgrade for Acadia Healthcare Co Inc happened on January 7, 2025 when Keybanc raised their price target to $70. Keybanc previously had a sector weight for Acadia Healthcare Co Inc.
The last downgrade for Acadia Healthcare Co Inc happened on February 28, 2025 when Barclays changed their price target from $43 to $35 for Acadia Healthcare Co Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Acadia Healthcare Co, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Acadia Healthcare Co was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
While ratings are subjective and will change, the latest Acadia Healthcare Co (ACHC) rating was a maintained with a price target of $37.00 to $32.00. The current price Acadia Healthcare Co (ACHC) is trading at is $26.16, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.